Related Experiment Videos
UVB photosensitivity due to ranitidine
1Department of Dermatology, School of Medicine, Sapporo Medical University, Sapporo, Japan. seiji@sapmed.ac.jp
Dermatology (Basel, Switzerland)
|September 6, 2000
Summary
Ranitidine can cause persistent photosensitivity, a condition where skin becomes highly sensitive to ultraviolet B (UVB) light. This reaction, confirmed by a positive oral challenge test, continued even after the medication was stopped.
Area of Science:
- Dermatology
- Pharmacology
- Toxicology
Background:
- Photosensitivity is an adverse drug reaction characterized by increased susceptibility to sunlight.
- Ranitidine, a histamine H2 receptor antagonist, is commonly prescribed for gastrointestinal conditions.
- Drug-induced photosensitivity can manifest as either phototoxic or photoallergic reactions.
Observation:
- A 62-year-old male presented with photosensitivity.
- The patient reported a history of photosensitivity potentially linked to ranitidine use.
- Symptoms were exacerbated by exposure to ultraviolet B (UVB) irradiation following oral ranitidine administration.
Findings:
- An oral challenge test involving ranitidine and UVB irradiation yielded a positive result, confirming ranitidine-induced photosensitivity.
- The observed photosensitivity persisted despite the discontinuation of ranitidine.
- This suggests a potentially prolonged or irreversible mechanism underlying the ranitidine-induced UVB photosensitivity.
Implications:
- Clinicians should consider ranitidine as a potential cause of UVB-induced photosensitivity in patients presenting with such symptoms.
- The persistent nature of this reaction highlights the importance of thorough medication history and potential long-term management strategies.
- Further research is warranted to elucidate the precise mechanisms of ranitidine-induced persistent photosensitivity.